{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:13Z","timestamp":1792783753492,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NHS"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.berh.2017.12.001","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T09:54:17Z","timestamp":1515664457000},"page":"596-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Periodic fever syndromes"],"prefix":"10.1016","volume":"31","author":[{"given":"Helen J.","family":"Lachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrrheum.2015.79","article-title":"From bench to bedside and back again: translational research in autoinflammation","volume":"11","author":"Holzinger","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.23120","article-title":"International retrospective chart review of treatment patterns in severe familial mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/all.12084","article-title":"Unexplained recurrent fever: when is autoinflammation the explanation?","volume":"68","author":"Kallinich","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.cdd.4402038","article-title":"Inflammatory caspases and inflammasomes: master switches of inflammation","volume":"14","author":"Martinon","year":"2007","journal-title":"Cell Death Differ"},{"issue":"206","key":"10.1016\/j.berh.2017.12.001_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In\u00a0vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"11","author":"Lachmann","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.berh.2017.12.001_bib7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1185\/03007990802081543","article-title":"Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives","volume":"24","author":"Stych","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/kew208","article-title":"Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes","volume":"55","author":"Kullenberg","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib12","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"23","key":"10.1016\/j.berh.2017.12.001_bib13","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.berh.2017.12.001_bib14","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/rheumatology\/kex185","article-title":"Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study","volume":"56","author":"Jaeger","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2017.12.001_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors","author":"Youngstein","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A\u00a0candidate gene for familial Mediterranean fever","volume":"17","year":"1997","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever","volume":"90","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/annrheumdis-2012-202580","article-title":"MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease","volume":"73","author":"Stoffels","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.berh.2017.12.001_bib21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s11427-014-4758-3","article-title":"Immunological function of familial Mediterranean fever disease protein Pyrin","volume":"57","author":"Yang","year":"2014","journal-title":"Sci China Life Sci"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/kei279","article-title":"Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations","volume":"45","author":"Lachmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4\u20135","key":"10.1016\/j.berh.2017.12.001_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2014.01.045","article-title":"Diagnostic criteria of familial Mediterranean fever","volume":"13","author":"Berkun","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/annrheumdis-2012-202932","article-title":"Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents","volume":"73","author":"Twig","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.berh.2017.12.001_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial mediterranean fever. A double-blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.berh.2017.12.001_bib27","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM197212212872514","article-title":"Colchicine for familial Mediterranean fever","volume":"287","author":"Goldfinger","year":"1972","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.berh.2017.12.001_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":"A\u00a0controlled trial of colchicine in preventing attacks of familial mediterranean fever","volume":"291","author":"Zemer","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00296-015-3408-9","article-title":"Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review","volume":"36","author":"Demirkaya","year":"2016","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib30","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13075-015-0765-4","article-title":"Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever","volume":"17","author":"G\u00fcl","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.berh.2017.12.001_bib34","first-page":"1708","article-title":"Protracted febrile myalgia in patients with familial Mediterranean fever","volume":"21","author":"Langevitz","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.001_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BOR.0000000000000314","article-title":"Alarming consequences - autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1","volume":"28","author":"Holzinger","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2013a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"70","author":"Braun-Falco","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2017.12.001_bib37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/rheumatology\/kew031","article-title":"Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome","volume":"55","author":"Omenetti","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib38","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00109-014-1150-5","article-title":"Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases","volume":"92","author":"Bachetti","year":"2014","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib41","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.39683","article-title":"Brief report: association of tumor necrosis factor receptor-associated periodic syndrome with gonosomal mosaicism of a novel 24-nucleotide TNFRSF1A deletion","volume":"68","author":"Rowczenio","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2011.04484.x","article-title":"Role of tumour necrosis factor (TNF)-\u03b1 and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis","volume":"166","author":"Caminero","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.berh.2017.12.001_bib43","first-page":"2035","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"71","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2017.12.001_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2017.12.001_bib46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2017.12.001_bib48","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","article-title":"Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study","volume":"76","author":"Gattorno","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib50","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.berh.2017.12.001_bib51","first-page":"821","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2017.02.033","article-title":"Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency","volume":"140","author":"Munoz","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"40","key":"10.1016\/j.berh.2017.12.001_bib53","doi-asserted-by":"crossref","first-page":"27757","DOI":"10.1074\/jbc.M114.571810","article-title":"Unprenylated RhoA contributes to IL-1\u03b2 hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity","volume":"289","author":"van der Burgh","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.berh.2017.12.001_bib54","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.berh.2017.12.001_bib55","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/art.40146","article-title":"Open-label, phase II study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome","volume":"69","author":"Arostegui","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 94","key":"10.1016\/j.berh.2017.12.001_bib56","first-page":"S46","article-title":"Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature","volume":"33","author":"Lane","year":"2015","journal-title":"Clin Exp Rheum"},{"issue":"23","key":"10.1016\/j.berh.2017.12.001_bib57","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.berh.2017.12.001_bib58","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2017.12.001_bib59","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/bjd.12805","article-title":"Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?","volume":"170","author":"Tauber","year":"2014","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib60","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/jdv.12590","article-title":"Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist","volume":"29","author":"Sugiura","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.001_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamadermatol.2016.5705","article-title":"Secukinumab for the treatment of deficiency of interleukin 36 receptor antagonist in an adolescent","volume":"153","author":"Molho-Pessach","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.berh.2017.12.001_bib62","article-title":"High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)","author":"Bonekamp","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5 Pt1","key":"10.1016\/j.berh.2017.12.001_bib63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3476(89)80650-X","article-title":"Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings","volume":"115","author":"Majeed","year":"1989","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.berh.2017.12.001_bib64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/jmg.2005.030759","article-title":"Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)","volume":"42","author":"Ferguson","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1084\/jem.20161452","article-title":"Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation","volume":"214","author":"Lord\u00e9n","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib67","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaci.2014.12.1941","article-title":"Somatic NOD2 mosaicism in Blau syndrome","volume":"136","author":"de Inocencio","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2017.12.001_bib68","article-title":"Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series","author":"Sarens","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.berh.2017.12.001_bib69","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3899\/jrheum.160672","article-title":"Tumor necrosis factor inhibitors provide longterm clinical benefits in pediatric and young adult patients with Blau syndrome","volume":"44","author":"Nagakura","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2017.12.001_bib71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit \u03b2 type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2017.12.001_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/DAD.0000000000000340","article-title":"Histologic and immunohistochemical features of the skin lesions in CANDLE syndrome","volume":"37","author":"Torrelo","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib73","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"A\u00a0progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib75","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167A","author":"Crow","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib76","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.berh.2017.12.001_bib77","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2017.12.001_bib78","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplantation rescues the hematological, immunological and vascular phenotype in DADA2","author":"Hashem","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib79","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10096-016-2623-y","article-title":"Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome","volume":"35","author":"Tejesvi","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.berh.2017.12.001_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3476(99)70321-5","article-title":"Periodic fever syndrome in children","volume":"135","author":"Thomas","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.berh.2017.12.001_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.berh.2014.05.005","article-title":"A\u00a0practical approach to the diagnosis of autoinflammatory diseases in childhood","volume":"28","author":"Federici","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2017.12.001_bib82","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/apa.13531","article-title":"Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome","volume":"105","author":"Wekell","year":"2016","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.berh.2017.12.001_bib83","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/adc.86.6.434","article-title":"PFAPA syndrome in children evaluated for tonsillectomy","volume":"86","author":"Galanakis","year":"2002","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.berh.2017.12.001_bib84","article-title":"Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)","volume":"11","author":"Burton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.berh.2017.12.001_bib85","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694217301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694217301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:48Z","timestamp":1761499128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694217301006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1521694217301006"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2017.12.001","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periodic fever syndromes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}